Tempest Therapeutics, Inc.TPSTNASDAQ
Loading
P/FCF Ratio Over TimeExpanding
Percentile Rank46
Studio
Year-over-Year Change

Price to free cash flow ratio

Latest
-9.05
↑ 40% vs avg
Percentile
P46
Within normal range
Streak
1 yr
Consecutive growthExpanding
Average
-15.07
Historical baseline
PeriodValueYoY Change
2024-9.05+71.8%
2023-32.03-7533.3%
2022-0.42+45.2%
2021-0.77-12.1%
2020-0.68+97.6%
2019-28.86-327.4%
2018-6.75-2773.0%
2017-0.23+97.6%
2016-9.94+84.0%
2015-61.94-